Home
>
National Drug Code (NDC)
>
Zidovudine
Zidovudine - 31722-509-60 - (Zidovudine)
Drug Information of Zidovudine
| Product NDC: | 31722-509 |
| Proprietary Name: | Zidovudine |
| Non Proprietary Name: | Zidovudine |
| Active Ingredient(s): | 300 mg/1 & nbsp; Zidovudine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zidovudine
| Product NDC: | 31722-509 |
| Labeler Name: | Camber Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090092 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110101 |
Package Information of Zidovudine
| Package NDC: | 31722-509-60 |
| Package Description: | 12 BOTTLE in 1 CASE (31722-509-60) > 60 TABLET in 1 BOTTLE |
NDC Information of Zidovudine
| NDC Code | 31722-509-60 |
| Proprietary Name | Zidovudine |
| Package Description | 12 BOTTLE in 1 CASE (31722-509-60) > 60 TABLET in 1 BOTTLE |
| Product NDC | 31722-509 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Zidovudine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110101 |
| Marketing Category Name | ANDA |
| Labeler Name | Camber Pharmaceuticals |
| Substance Name | ZIDOVUDINE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
